GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Net Income From Continuing Operations

GSK (BUE:GSK) Net Income From Continuing Operations : ARS3,364,329 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is GSK Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. GSK's net income from continuing operations for the three months ended in Dec. 2024 was ARS639,709 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was ARS3,364,329 Mil.

GSK Net Income From Continuing Operations Historical Data

The historical data trend for GSK's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Net Income From Continuing Operations Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 558,174.90 472,181.96 1,004,878.95 2,425,554.43 3,768,027.81

GSK Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181,870.89 1,157,233.16 1,485,664.12 81,722.88 639,709.23

GSK Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS3,364,329 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Net Income From Continuing Operations
Comparable Companies
LSE:AZN LLY OCSE:NOVO B JNJ ABBV XSWX:ROG MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 TSE:4578 XTER:BAYN BIIB TSE:4503
Traded in Other Exchanges
GLAXF:USA GSK:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany G1SK34:Brazil
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.